# Comprehensive Structure for Literature Review on ADMET Prediction Tools

## 1. Introduction
- 1.1 Background and significance of ADMET properties in drug discovery
- 1.2 Challenges in experimental determination of ADMET properties
- 1.3 Evolution of computational approaches for ADMET prediction
- 1.4 Scope and objectives of this review

## 2. Methodology
- 2.1 Literature search strategy and selection criteria
- 2.2 Classification framework for ADMET prediction tools
- 2.3 Evaluation metrics for assessing prediction tools

## 3. Traditional ADMET Prediction Approaches
- 3.1 Rule-based methods
  - 3.1.1 Lipinski's Rule of Five and extensions
  - 3.1.2 PAINS filters and other structural alerts
- 3.2 QSAR and QSPR models
  - 3.2.1 Linear and non-linear regression models
  - 3.2.2 Descriptor selection and optimization
- 3.3 Pharmacophore-based approaches
- 3.4 Structure-based methods
  - 3.4.1 Molecular docking
  - 3.4.2 Molecular dynamics simulations

## 4. Machine Learning Approaches for ADMET Prediction
- 4.1 Classical machine learning methods
  - 4.1.1 Random forests
  - 4.1.2 Support vector machines
  - 4.1.3 Gradient boosting methods
- 4.2 Deep learning approaches
  - 4.2.1 Feed-forward neural networks
  - 4.2.2 Convolutional neural networks
  - 4.2.3 Recurrent neural networks
  - 4.2.4 Graph neural networks
  - 4.2.5 Transformer-based models
- 4.3 Transfer learning and multi-task learning
- 4.4 Representation learning for molecular structures

## 5. Specific ADMET Property Prediction Tools
- 5.1 Absorption prediction tools
  - 5.1.1 Intestinal absorption models
  - 5.1.2 Blood-brain barrier penetration
  - 5.1.3 Bioavailability prediction
- 5.2 Distribution prediction tools
  - 5.2.1 Plasma protein binding
  - 5.2.2 Volume of distribution
  - 5.2.3 Tissue distribution
- 5.3 Metabolism prediction tools
  - 5.3.1 CYP450 substrate/inhibitor prediction
  - 5.3.2 Phase II metabolism prediction
  - 5.3.3 Metabolite identification
- 5.4 Excretion prediction tools
  - 5.4.1 Renal clearance models
  - 5.4.2 Biliary excretion prediction
  - 5.4.3 Half-life prediction
- 5.5 Toxicity prediction tools
  - 5.5.1 Organ-specific toxicity
  - 5.5.2 Genotoxicity and carcinogenicity
  - 5.5.3 hERG inhibition and cardiotoxicity
  - 5.5.4 Hepatotoxicity prediction
  - 5.5.5 Reproductive and developmental toxicity

## 6. Integrated ADMET Platforms and Workflows
- 6.1 Commercial software platforms
- 6.2 Open-source tools and resources
- 6.3 Web-based prediction services
- 6.4 Integration with molecular design workflows

## 7. Validation and Benchmarking
- 7.1 Benchmark datasets for ADMET prediction
- 7.2 Performance metrics and evaluation protocols
- 7.3 Cross-validation strategies
- 7.4 External validation approaches
- 7.5 Applicability domain assessment

## 8. Emerging Trends and Future Directions
- 8.1 Explainable AI for ADMET prediction
- 8.2 Integration of multi-omics data
- 8.3 Quantum computing applications
- 8.4 Federated learning for proprietary data utilization
- 8.5 Active learning and adaptive experimental design

## 9. Challenges and Limitations
- 9.1 Data quality and availability issues
- 9.2 Handling of experimental uncertainty
- 9.3 Prediction confidence and reliability
- 9.4 Generalizability across chemical spaces
- 9.5 Integration of in silico, in vitro, and in vivo data

## 10. Applications in Drug Discovery
- 10.1 Early-stage compound screening
- 10.2 Lead optimization
- 10.3 Drug repurposing
- 10.4 De novo molecular design with ADMET constraints
- 10.5 Case studies of successful applications

## 11. Regulatory Perspectives
- 11.1 Acceptance of in silico methods by regulatory agencies
- 11.2 Guidelines for validation and reporting
- 11.3 Integration into risk assessment frameworks

## 12. Conclusions and Outlook
- 12.1 Summary of current state-of-the-art
- 12.2 Key challenges and opportunities
- 12.3 Recommendations for future research

## 13. References
- Categorized by ADMET property and methodology

## Appendices
- A. Glossary of terms
- B. List of publicly available ADMET datasets
- C. Comparison table of prediction tools by performance metrics
- D. Software availability and accessibility information